Latest News

Triple therapy revs up immune system against common brain tumor

A triple therapy for glioblastoma, including two types of immunotherapy and targeted radiation, has significantly prolonged the survival of mice with these brain cancers, according to a new report. Mice with implanted, mouse-derived glioblastoma cells lived an average of 67 days after the triple therapy, compared with mice that lasted 24 days when they received only the two immunotherapies.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Trust your aha! moments: Experiments show they're probably right

  • Scientists use synthetic gene and magnets to alter behavior of mice, fish

  • Teen girls see big drop in chemical exposure with switch in cosmetics

  • Female traders can reduce market crashes, expert says

  • Toxic byproduct of hemoglobin could provide clues for cerebral hemorrhage and Creutzfeldt-Jakob Disease

  • Clinician communication reduced distress related to the detection of incidental nodules

  • Talk about yourself on social media?

  • New mothers with postpartum psychiatric disorders face increased risk of suicide, study shows

  • Combining two techniques to 'rewire' the brain may improve arm, hand movement for stroke survivors

  • Scientists map roots of premeditated, violent 'intent' in animal brain

  •